Nagisa Hasegawa-Oshima
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Daratumumab (anti-CD38)- and elotuzumab (anti-SLAMF7)-based treatments for refractory POEMS syndrome: a single-center case series.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 18, 2025
Clinical Impact of Osteolytic Bone Lesions in POEMS Syndrome: A Single-Center Experience of 114 Patients.
Journal: Hematological oncology
Published: May 18, 2024
Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation.
Journal: International journal of hematology
Published: December 06, 2023
Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry.
Journal: Scientific reports
Published: April 06, 2023
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression.
Journal: Leukemia
Published: November 26, 2022
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2022
Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease.
Journal: Leukemia research reports
Published: August 10, 2021
Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Journal: Experimental hematology
Published: April 15, 2021
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.
Journal: British journal of haematology
Published: March 22, 2021
Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation.
Journal: International journal of hematology
Published: January 29, 2021
Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
Journal: Bone marrow transplantation
Published: July 06, 2020
Last Updated: 09/26/2026